According to our results, Foxp1 mRNA expression level in paracancerous tissue was lower than that of I–II patients with bladder cancer, and Foxp1 mRNA expression of I–II patients with bladder cancer was lower than that of III–IV patients with bladder cancer (Figure 1c). Here, FOXP1 is linked to urinary bladder cancer.